Joint Venture (Tables)

12 Months Ended

Jun. 30, 2023

Equity Method Investments and Joint Ventures [Abstract]

Summary of Reconciliation Between the Carrying Value of Investment and Proportional Share of Underlying Equity in Net Assets of Joint Ventures

The following table shows the reconciliation between the carrying value of the Company's investment in the JV and its proportional share of the underlying equity in net assets of the JV (in thousands):

	June 30, 2023			June 30, 2022
Carrying value of investment in joint venture	$	15,128		$	13,879
Deferred intra-entity profit margin		5,737			5,456
Equity method goodwill		(4,720	)		(4,720	)
Proportional share of equity investment in joint venture	$	16,145		$	14,615

Summary of Financial Information of Joint Ventures (Operations Data)

Summarized financial information of the JV is as follows (in thousands):

Statement of Operations Data:	Twelve Months Ended March 31, 2023		Twelve Months Ended March 31, 2022		Twelve Months Ended March 31, 2021
Revenue	$	109,097	$	55,190	$	33,054
Gross profit	$	21,522	$	15,915	$	10,578
Net income	$	5,280	$	422	$	1,785
Net income attributable to the Company	$	2,572	$	241	$	872

Summary of Financial Information of Joint Ventures (Balance Sheet Data)

Summarized Balance Sheet Data:	As of March 31, 2023		As of March 31, 2022
Assets
Current assets	$	87,662	$	71,730
Non current assets		16,504		21,754
Total assets	$	104,166	$	93,484
Liabilities and Stockholders' Equity
Current liabilities	$	70,189	$	61,877
Non current liabilities		398		1,055
Stockholder's equity		33,579		30,552
Total liabilities and stockholders' equity	$	104,166	$	93,484

Schedule of Deferred Intra Entity Profit Margin from Sales

The following table shows the activity of the Company’s deferred intra-entity profit margin from sales (in thousands):

	Years Ended June 30,
	2023			2022			2021
Previously deferred intra-entity profit margin from sales - recognized	$	(10,436	)	$	(4,007	)	$	(2,403	)
Intra-entity profit margin from sales - deferred		10,718			7,307			2,713
Total change in deferred intra-entity profit margin from sales	$	282		$	3,300		$	310